Evidence map›Paper›PMID 23536211›Full record

ArticleEuropean child & adolescent psychiatry2013

Infants at risk for autism: a European perspective on current status, challenges and opportunities.

Sven Bölte, Peter B Marschik, Terje Falck-Ytter, Tony Charman, Herbert Roeyers, Mayada Elsabbagh

Open access · hybridAbstract read
In one paragraph

Article in European child & adolescent psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Identifying Atypical Development: A Role of Day-Care Workers?Journal of autism and developmental disorders · 2019
    Article
  8. Review
  9. Local and Global Visual Processing in 3-Year-Olds With and Without Autism.Journal of autism and developmental disorders · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Towards a second-person neuropsychiatry.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

Sven BölteCenter of Neurodevelopmental Disorders (KIND), Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital, Q2:07, 17176 Stockholm, Sweden. sven.bolte@ki.se
Peter B Marschik
Terje Falck-Ytter
Tony Charman
Herbert Roeyers
Mayada Elsabbagh
Ghent University Hospital · BEKarolinska Institutet · SEKing's College London · GBMcGill University · CAMedical University of Graz · ATUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, autism cannot be reliably diagnosed before the age of 2 years, which is why longitudinal studies of high-risk populations provide the potential to generate unique knowledge about the development of autism during infancy and toddlerhood prior to symptom onset. Early autism research is an evolving field in child psychiatric science. Key objectives are fine mapping of neurodevelopmental trajectories and identifying biomarkers to improve risk assessment, diagnosis and treatment. ESSEA (Enhancing the Scientific Study of Early Autism) is a COST (European Cooperation in Science and Technology) Action striving to create a European collaboration to enhance the progress of the discovery and treatment of the earliest signs of autism, and to establish European practice guidelines on early identification and intervention by bringing together European expertise from cognitive neuroscience and clinical sciences. The objective of this article is to clarify the state of current European research on at-risk autism research, and to support the understanding of different contexts in which the research is being conducted. We present ESSEA survey data on ongoing European high-risk ASD studies, as well as perceived challenges and opportunities in this field of research. We conclude that although high-risk autism research in Europe faces several challenges, the existence of several key factors (e.g., new and/or large-scale autism grants, availability of new technologies, and involvement of experienced research groups) lead us to expect substantial scientific and clinical developments in Europe in this field during the next few years.

Indexed as

Autistic DisorderChildChild, PreschoolEuropeFemaleHumansInfantLongitudinal StudiesMaleRisk Factors

Identifiers

PMID23536211
PMCPMC3669501
OpenAlexW2161284010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.